MCRB Stock Analysis: Buy, Sell, or Hold?
MCRB - Seres Therapeutics, Inc.
$7.09
0.00 (0.00%)
▲
5d:
-16.0%
30d:
-19.43%
90d:
-53.17%
WAIT
LOW Confidence
Analysis Updated: Apr 28, 2026 12:00 AM ET
Earnings: May 06, 2026
6d
Smart Money Distribution
MCRB is up 6.9% this week, but smart money is buying puts. Top strike: $7.5 2026-06-18 with 1 OI. Put ratio: 100% View Scanner →
Strength: 8.4/10
Get Alerted When MCRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MCRB is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MCRB is down 16.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MCRB is currently trading at $7.09, which is considered oversold relative to its 30-day fair value range of $7.98 to $9.13.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $6.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+210.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $6.98. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (5th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.00 (+210.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.98 -
$9.13
Company Quality Score
48/100
(HOLD)
Options IV Signal
5th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding MCRB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 5th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 210.3% below Wall St target ($22.00)
- WARNING: Recommendation downgraded due to -16.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.98 -
$9.13
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.30
(18.3%)
Support & Resistance Levels
Support Level
$6.98
Resistance Level
$9.11
Current Trend
Strong Downtrend
Technical data as of
Apr 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.77
Wall Street Target
$22.00
(+210.3%)
Revenue Growth (YoY)
-93.4%
Earnings Growth (YoY)
-91.9%
Profit Margin
721.9%
Share & Embed Analysis
Last updated: April 29, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MCRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric D Shaff
SELL
217 shares
2025-11-15
Matthew R Henn
SELL
1257 shares
2025-11-15
Thomas Desrosier
SELL
76 shares
2025-11-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 59 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$878 | 58 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$226 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 55 HOLD |
Advanced MCRB Option Strategies
Professional options setups generated by AI based on today's MCRB price and gamma walls.
